Search

Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, including lung and endometrial cancers.

… Monday, October 28, 2024 Obesity or being overweight can  increase your risk of developing cancer . It can lead to chronic inflammation and hormonal changes, which can damage DNA and cause uncontrolled cell growth.  Now new research at Memorial Sloan Kettering Cancer Center (MSK) suggests obesity may

In a first-of-its-kind collaboration, MSK has joined forces with the Chinese Thoracic Oncology Group in an effort to establish a program of clinical trials that are open to patients from both the United States and China.

… Friday, April 19, 2019 In a first-of-its-kind collaboration, Memorial Sloan Kettering has joined forces with the Chinese Thoracic Oncology Group (CTONG) — an alliance of more than 20 premier academic cancer centers in China — in an effort to establish a program of clinical trials that are open to patients

在史上首次该类型合作中，MSK 与中国胸部肿瘤研究协作组将携手共进，共同打造一个对来自美国和中国的患者都开放的临床试验项目。

… Friday, April 19, 2019 中国胸部肿瘤研究协作组 (CTONG) 是由 20 多个中国顶尖学术癌症中心组成的联盟。Memorial Sloan Kettering 首次与 CTONG 合作，努力促成一项对中美两国患者开放的临床试验项目。 该举措将重点关注 肺癌 精准治疗的临床试验。在中美两国，肺癌都是癌症致死的头号杀手。 此次合作于去年 12 月正式启动，旨在为中美两国的多中心 临床试验 奠定学术基础，最终目标是提高临床试验参与率，推动有效的新疗法尽快获批。 合作期间还实施了其他显著措施，包括远程医疗和教育举措，旨在改善两国患者的护理状况，并努力推动行业参与。 为获得该领域的指导

While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines.

… Thursday, April 23, 2020 While we stay home to flatten the curve of COVID-19, hardworking healthcare professionals are putting in long hours on the front lines. Memorial Sloan Kettering Cancer Center (MSK) is encouraging our healthcare heroes to take a moment to recharge during this challenging time.

MSK molecular geneticist and data scientist Elli Papaemmanuil is leading an initiative to identify the genomic changes that drive pediatric tumors.

… Monday, September 30, 2019 Summary About half of pediatric tumors have a significant mutation that can be identified with standard clinical tests. MSK researchers are looking for a better way to detect mutations in the rest. MSK-IMPACT ™ detects changes in more than 400 cancer-associated genes. The test

Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms.

… Friday, December 8, 2017 Donna D’Alessio, MD Donna D’Alessio, MD Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms

Researchers at Memorial Sloan Kettering Cancer Center (MSK), have published the first systemic review of the association between industry payments and physician prescribing in order to determine whether evidence is sufficient to conclude that payments cause physicians to change their prescribing practices across a broad range of  medical specialties and drug types.

… Monday, November 23, 2020 Researchers at Memorial Sloan Kettering Cancer Center (MSK), led by Aaron Mitchell, MD, MPH, a medical oncologist and health services researcher in the  Department of Epidemiology and Biostatistics , have published the first systemic review of the association between industry

Wondering how cryo-electron microscopy will impact medicine? Hear it from the source.

… Friday, September 9, 2016 Summary Memorial Sloan Kettering recently acquired a powerful new microscope that promises to greatly enhance scientists’ ability to understand the structure and function of biological molecules — including those that malfunction in cancer. In biology, structure and function

A single surviving myeloma cell can seed accelerated relapse, and more than 20 percent of nonsynonymous mutations at relapse may be induced by exposure to chemotherapy such as platinum and high-dose melphalan after autologous stem cell transplant.

… Friday, August 14, 2020 A single surviving myeloma cell can seed accelerated relapse, and more than 20 percent of nonsynonymous mutations at relapse may be induced by exposure to chemotherapy such as platinum and high-dose melphalan after autologous stem cell transplant, according to our research, published

Learn why an MSK patient is supporting the MSK mission with a bequest.

… Tuesday, November 7, 2023 Claire Theobald’s journey with breast cancer has taught her to cherish every small, beautiful moment of life. It has also inspired her to include Memorial Sloan Kettering Cancer Center (MSK) in her estate planning by making a bequest to MSK in her will. Her hope, she explains